📰 Presentation Date News
Page 2 - Presentation Date News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Presentation Date. Real-time updates on events, politics, business and more.
May 10, 2023
Late-breaking Phase 2 proof-of-concept study in Prader-Willi syndrome accepted for poster presentation PLYMOUTH MEETING, Pa., May 10, 2023 /PRNewswire/ -- Harmony Biosciences Holdings, Inc. , a... | May 10, 2023
May 10, 2023
Harmony Biosciences will present new efficacy data from a phase 2 study evaluating pitolisant in patients with Prader-Willi syndrome.
November 28, 2022
28.11.2022 - Management Team to Highlight Strong Revenue Growth and Partnership with Cuentas, Inc.NEW YORK, NY / ACCESSWIRE / November 28, 2022 / OLB Group, Inc. (NASDAQ:OLB), a diversified Fintech eCommerce merchant services provider and cryptocurrency mining ... Seite 1
November 7, 2022
/PRNewswire/ -- Obsidian Therapeutics, Inc., a clinical-stage biotechnology company pioneering engineered cell and gene therapies, today announced it will...
November 7, 2022
Improved Anti-Tumor Activity Demonstrated by the Combination of NKX019 and a CD20-directed Monoclonal Antibody in Preclinical Models Pulsed Stimulation of...
November 2, 2022
BOSTON--(BUSINESS WIRE)--#TLM22--PathAI, a global leader in artificial intelligence (AI)-powered technology for pathology, today announced that the organization’s recent research will be presented at the upcoming 2022 AASLD 2022 Liver Meeting*, which will be held in Washington, D.C. from November 4-8, 2022. At this...
October 28, 2022
/PRNewswire/ -- LISCure Biosciences, a clinical-stage biopharmaceutical company developing microbe-oriented new drugs based on innovative technologies, today...
June 2, 2022
Corporate Presentation to Highlight Companys Gene Therapies for Cancer and DiabetesAUSTIN, Texas , June 2, 2022 /PRNewswire/ -- Genprex, Inc. (G...
May 19, 2022
/PRNewswire/ -- Genprex, Inc. ("Genprex" or the "Company") (NASDAQ: GNPX), a clinical-stage gene therapy company focused on developing life-changing therapies...
April 18, 2022
/PRNewswire/ -- Genprex, Inc. ("Genprex" or the "Company") (NASDAQ: GNPX), a clinical-stage gene therapy company focused on developing life-changing therapies...